Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Protein Networks02:26

Protein Networks

3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.3K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

474
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
474
Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

250
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
250
Passive Diffusion: Overview and Kinetics01:17

Passive Diffusion: Overview and Kinetics

358
Passive diffusion is a critical process that allows small lipophilic drugs to cross the cell membrane along a concentration gradient. This mechanism's efficiency depends on four primary factors: the membrane's surface area, the drug's lipid-water partition coefficient, the concentration gradient, and the membrane's thickness.
When administered orally, drugs establish a substantial concentration gradient between the gastrointestinal (GI) lumen and the bloodstream, expediting...
358
Facilitated Diffusion01:16

Facilitated Diffusion

268
The plasma membrane, a critical structure in cellular biology, houses an array of transporters, or carrier proteins, interspersed within its lipid bilayer. These proteins play a crucial role in solute transport through facilitated diffusion, a form of passive diffusion that uses transporters to move the molecules across the membrane.
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
268

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Trainable clustering framework for spatial transcriptomics.

Bioinformatics advances·2026
Same author

The good, the bad, and the ugly: opportunities, challenges, and pitfalls in spatial proteomics modeling.

Briefings in bioinformatics·2026
Same author

Spatial information matters: are traditional imputation methods effective for spatial transcriptomics data?

Briefings in bioinformatics·2026
Same author

Polyp segmentation in colonoscopy images using DeepLabV3+.

Computers in biology and medicine·2025
Same author

ElectroCom61: A multiclass dataset for detection of electronic components.

Data in brief·2025
Same author

DeepPhoPred: Accurate Deep Learning Model to Predict Microbial Phosphorylation.

Proteins·2024
Same journal

Region-aware bridge modeling enables interpretable mesoscale representation of spatial transcriptomic tissue sections.

Bioinformatics advances·2026
Same journal

Microbiome differential abundance methodologies to detect relevant taxa associated with chemotherapy toxicity rate in colorectal cancer.

Bioinformatics advances·2026
Same journal

maldipickr dereplicates microbial MALDI-TOF spectra to facilitate multiplexed isolation.

Bioinformatics advances·2026
Same journal

RAM-MSA: an anytime memory-bounded method for exact multiple sequence alignment using path finding.

Bioinformatics advances·2026
Same journal

Interpretable machine learning for low-sample multi-omics: a case study of ferret vaccine response.

Bioinformatics advances·2026
Same journal

DeepTaxa: a hybrid CNN-BERT framework for 16S rRNA taxonomic classification.

Bioinformatics advances·2026
查看所有相关文章

相关实验视频

Updated: Jun 17, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

CoDNet:基于结构的药物设计的受控扩散网络.

Fahmi Kazi Md1, Shahil Yasar Haque1, Eashrat Jahan1

  • 1Department of Computer Science and Engineering, United International University, Dhaka 1212, Bangladesh.

Bioinformatics advances
|March 10, 2025
PubMed
概括
此摘要是机器生成的。

CoDNet是一个新的生成框架,通过集成ControlNet和扩散模型来提高基于结构的药物设计,以实现高效的分子化合物生成. 它实现了高的有效率,推动了药物发现.

更多相关视频

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

相关实验视频

Last Updated: Jun 17, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

科学领域:

  • 计算化学是一种计算化学.
  • 药品化学 药品化学 是一个
  • 人工智能在药物发现中的作用

背景情况:

  • 基于结构的药物设计 (SBDD) 通过利用3D目标结构来优化治疗剂.
  • 提高连接体结合亲和力和选择性对于有效的药物开发至关重要.

研究的目的:

  • 介绍 CoDNet,这是一个用于分子化合物设计的新型生成框架.
  • 在基于扩散模型的药物开发中率先应用ControlNet.

主要方法:

  • CoDNet将ControlNet的调节能力与生成分子设计的扩散模型相结合.
  • 该方法直接从3D形状生成类似药物的化合物,整合分子和键信息.
  • 它绕过了传统的后处理步骤,如Open Babel.

主要成果:

  • 在QM9数据集上,CoDNet实现了99.02%的有效率,超过了现有的最先进的方法.
  • 该模型在生成有效的分子结构方面表现出高精度和有效性.
  • 这一表现突显了CoDNet在推动药物发现倡议方面的潜力.

结论:

  • CoDNet代表了分子化合物设计的生成框架的重大进步.
  • 该方法为基于结构的药物设计提供了一个强大的工具,提高了效率和准确性.
  • 它的成功应用表明了将先进的人工智能技术整合到药物开发中的潜力.